Family Medicine · Provo, UT
NPI
1093703530
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2230 N University Pkwy, Suite 1a
Provo, UT, 84604
Phone (801) 377-3413
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$315K
2,480 prescriptions
Company payments, 2025
$1,014
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug James A Woodmansee III prescribed most often to Medicare patients was Zolpidem Tartrate, with 125 prescriptions and refills. In total James A Woodmansee III wrote 2,480 Medicare prescriptions that cost $315K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Zolpidem Tartrate Generic | 125 | 163 | 23 | $1,354 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 91 | 91 | 16 | $2,744 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 79 | 79 | 16 | $916 |
| Levothyroxine Sodium Generic | 64 | 155 | 18 | $818 |
| Sertraline Hcl Generic | 57 | 97 | 13 | $558 |
| Rosuvastatin Calcium Generic | 50 | 108 | Under 11 | $628 |
| Eliquis Apixaban | 50 | 60 | Under 11 | $32K |
| Tamsulosin Hcl Generic | 47 | 76 | 13 | $456 |
| Gabapentin Generic | 46 | 71 | 13 | $675 |
| Alprazolam Generic | 44 | 46 | Under 11 | $201 |
| Celecoxib Generic | 43 | 83 | 12 | $803 |
| Omeprazole Generic | 43 | 76 | Under 11 | $756 |
| Lisinopril Generic | 43 | 122 | 15 | $424 |
| Azithromycin Generic | 41 | 41 | 32 | $166 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 38 | 38 | 13 | $933 |
Brand drugs: 261 claims; generic drugs: 2,206 claims; opioid claims: 201.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Woodmansee III $1,014 ($1,014 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $237.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $140 |
| Astellas Pharma US Inc 4503.T | 6 | $125 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $116 |
| Pfizer Inc. PFE | 4 | $68.73 |
| Bausch Health US, LLC BHC | 2 | $44.71 |
| Corium, LLC | 2 | $35.9 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $34.05 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $29.02 |
| Biogen, Inc. BIIB | 1 | $23.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.